Richard C. Yocum
2008 - Halozyme Therapeutics
In 2008, Richard C. Yocum earned a total compensation of $406.3K as Vice President — Clinical Development and Medical Affairs at Halozyme Therapeutics, a 3% decrease compared to previous year.
Compensation breakdown
| Option Awards | $105,899 |
|---|---|
| Salary | $300,000 |
| Other | $360 |
| Total | $406,259 |
Yocum received $300K in salary, accounting for 74% of the total pay in 2008.
Yocum also received $105.9K in option awards and $360 in other compensation.
Rankings
In 2008, Richard C. Yocum's compensation ranked 7,113th out of 9,135 executives tracked by ExecPay. In other words, Yocum earned more than 22.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,113 out of 9,135 | 22nd |
Division Manufacturing | 2,661 out of 3,436 | 23rd |
Major group Chemicals And Allied Products | 602 out of 815 | 26th |
Industry group Drugs | 425 out of 597 | 29th |
Industry Biological Products, Except Diagnostic Substances | 76 out of 118 | 36th |
Source: SEC filing on April 2, 2009.
Yocum's colleagues
We found six more compensation records of executives who worked with Richard C. Yocum at Halozyme Therapeutics in 2008.
2008
Jonathan Lim
Halozyme Therapeutics
Chief Executive Officer
2008
Gregory Frost
Halozyme Therapeutics
Chief Executive Officer
2008
Michael LaBarre
Halozyme Therapeutics
Vice President, Product Development
2008
Robert Little
Halozyme Therapeutics
Vice President and Chief Commercial Officer
2008
William Fallon
Halozyme Therapeutics
Vice President, Manufacturing & Operations
2008
David Ramsay
Halozyme Therapeutics